secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001628280-23-022421
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aadi Bioscience annual meeting elects directors, says-on-pay passes, auditor ratified
--------------------------------------------------------------------------------

- Elected three Class III directors: Aghazadeh (8.36M for), Maroun (9.87M), Reeve (9.87M).
- Advisory say-on-pay approved: 9.74M for, 0.28M against, 17K abstentions.
- Shareholders voted for annual say-on-pay frequency (9.83M for 1 year); next vote by 2029.
- Ratified BDO USA as auditor for FY2023: 13.85M for, 73K against, 3K abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000162828023022421/0001628280-23-022421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000162828023022421/aadi-20230614.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-022421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer